Bryn Mawr Capital Management LLC Has $17.83 Million Stock Holdings in The Cigna Group (NYSE:CI)

Bryn Mawr Capital Management LLC boosted its stake in The Cigna Group (NYSE:CIFree Report) by 5,367.4% during the fourth quarter, according to the company in its most recent filing with the SEC. The fund owned 64,570 shares of the health services provider’s stock after buying an additional 63,389 shares during the period. Bryn Mawr Capital Management LLC’s holdings in The Cigna Group were worth $17,830,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of CI. Alberta Investment Management Corp bought a new position in The Cigna Group during the 4th quarter worth $608,000. Financial Perspectives Inc increased its position in The Cigna Group by 6,200.0% during the fourth quarter. Financial Perspectives Inc now owns 378 shares of the health services provider’s stock worth $104,000 after acquiring an additional 372 shares during the period. Davidson Investment Advisors raised its stake in The Cigna Group by 1.0% in the 4th quarter. Davidson Investment Advisors now owns 53,846 shares of the health services provider’s stock worth $14,869,000 after purchasing an additional 559 shares in the last quarter. Valley Wealth Managers Inc. grew its position in shares of The Cigna Group by 2.8% during the 4th quarter. Valley Wealth Managers Inc. now owns 56,933 shares of the health services provider’s stock worth $15,721,000 after purchasing an additional 1,548 shares in the last quarter. Finally, Kestra Investment Management LLC increased its holdings in shares of The Cigna Group by 63.5% during the fourth quarter. Kestra Investment Management LLC now owns 3,297 shares of the health services provider’s stock worth $911,000 after purchasing an additional 1,281 shares during the period. 86.99% of the stock is owned by institutional investors.

The Cigna Group Stock Performance

The Cigna Group stock opened at $297.27 on Thursday. The business has a 50 day moving average of $285.65 and a 200-day moving average of $319.92. The company has a market capitalization of $82.69 billion, a P/E ratio of 24.29, a P/E/G ratio of 0.96 and a beta of 0.54. The Cigna Group has a 1 year low of $262.03 and a 1 year high of $370.83. The company has a debt-to-equity ratio of 0.70, a current ratio of 0.66 and a quick ratio of 0.72.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Thursday, January 30th. The health services provider reported $6.64 earnings per share (EPS) for the quarter, missing the consensus estimate of $7.84 by ($1.20). The Cigna Group had a net margin of 1.39% and a return on equity of 18.61%. During the same quarter last year, the firm earned $6.79 earnings per share. On average, equities research analysts predict that The Cigna Group will post 29.77 earnings per share for the current year.

The Cigna Group Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, March 20th. Shareholders of record on Wednesday, March 5th will be given a $1.51 dividend. This represents a $6.04 dividend on an annualized basis and a dividend yield of 2.03%. The ex-dividend date is Wednesday, March 5th. This is a positive change from The Cigna Group’s previous quarterly dividend of $1.40. The Cigna Group’s payout ratio is 49.35%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on CI shares. Deutsche Bank Aktiengesellschaft cut their price target on The Cigna Group from $398.00 to $394.00 and set a “buy” rating for the company in a research note on Monday, November 4th. Cantor Fitzgerald decreased their price target on The Cigna Group from $400.00 to $350.00 and set an “overweight” rating on the stock in a research report on Friday, January 31st. StockNews.com raised shares of The Cigna Group from a “hold” rating to a “buy” rating in a research report on Wednesday. Royal Bank of Canada decreased their target price on shares of The Cigna Group from $384.00 to $377.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Finally, Truist Financial cut their price target on shares of The Cigna Group from $390.00 to $375.00 and set a “buy” rating for the company in a report on Tuesday, February 4th. Two analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat.com, The Cigna Group presently has an average rating of “Buy” and an average target price of $373.69.

Read Our Latest Research Report on CI

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Recommended Stories

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.